Oncologica
bd_2a42a316b1e62103 · schema v1 · pii pii-v1
Full breach record for Oncologica →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group Timc on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
We breached into their intranet and have total control of it , with 1TB+ data exfiltrated including covid-19 database and SaaS src code like oncomine KB and Other PII Full data breach after the DDL
J jump to incidentP pin to compareR raw source
Incident timeline — mostly unverified
? — ?
Breach window unknown
Apr 9, 2026
Claim posted
—
No filing yet · watching
Compliance clocks stay unassessable until a regulatory filing lands. Dashed segments fill in automatically when corroboration arrives.
Claim → filing
—
Compliance clock
Not assessable
Evidence ladder
Attacker assertion only. Establishes: claim date, group, alleged victim.
Unlocks: incident narrative, operational impact. Still no compliance clock.
Unlocks: discovery date, data types, affected count, compliance clock.
Unlocks: materiality, stated response, full audit trail. Ceiling removed.
No regulatory filing corroborates this yet — it is the attacker's own assertion. Watch this entity to be notified the moment a filing corroborates or contradicts it.
Source ceiling
- actor name
- victim claim
- ransom/leak status
- discovery date
- materiality
- notification
- affected count
- confirmed data types
- compliance clock
The ✕ fields stay blank until a regulatory filing or victim disclosure lands.
timc
According to ransomware.live, TiMc is a ransomware group that emerged in early 2026, claiming high-impact attacks against Spanish IT services leader Seidor (1 TB+ data) and oncology organization Oncologica (100 GB+), targeting Business Services, Healthcare, and IT sectors with a focus on Spanish-speaking and European targets.